USPTO serial 79152345
TCF
Reviewed by CopyMark Law Group
Reg. 4903231Status 706Registered
- Filing date
- Status date
- Registration date
- Feb 23, 2016
- Examiner
- ALTREE, NICHOLAS
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with TCF?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
US
US
XH Amsterdam, NL
XH Amsterdam, NL
XH Amsterdam, NL
DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cynthia Smuzynska
Cynthia Smuzynska GILEAD SCIENCES INC.,333 Lakeside DriveFoster City, CA 94404United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ chemical preparations for industrial and scientific use, namely, polypeptides and proteins made by genetic engineering, including fusion proteins as well as nucleic acids encoding these polypeptides and proteins, namely, body cells and cells of the immune system of mammals, including human cells; analytical kits consisting of chemical reagents for industrial and scientific use, for the purification, detection and immobilization of fusion proteins, fusion peptides and cells, namely, body cells and cells of the immune system of mammals, including human cells; diagnostic preparations except for medical purposes ] | SECTION 71 - CANCELLED | — |
| 005 | pharmaceutical [ and veterinary ] preparations for the treatment of cancer, including hematologic cancers, [ viral mediated diseases, bacterial mediated diseases, and inflammatory and autoimmune diseases, including rheumatoid arthritis, osteoarthritis, Crohn's disease, psoriasis, psoriatic arthritis, ], namely, polypeptides and proteins made by genetic engineering, including fusion proteins, cells, namely, body cells and cells of the immune system of mammals, including human cells [ ; diagnostic preparations for medical purposes ] | ACTIVE | — |
| 042 | [ Scientific and industrial research in the field of biochemistry, diagnostics and pharmaceutics; biochemical or pharmaceutical laboratory services, namely, synthesis of recombinant polypeptides and proteins, cultivation and purification of cells, namely, of body cells and cells of the immune system of mammals including human cells ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kite Pharma, Inc.
- Other trademarks owned by Kite Pharma, Inc.
- Other trademarks owned by Kite Pharma EU B.V.
- Other trademarks owned by Kite Pharma EU B.V.
- Other trademarks owned by Kite Pharma EU B.V.
- Other trademarks owned by Dirk Busch
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named TCF
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 24, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 22, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 22, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Dec 22, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Dec 2, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 1, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Feb 23, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Mar 15, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Sep 11, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 23, 2023 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 23, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jun 19, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 19, 2022 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Oct 19, 2022 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 19, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Feb 18, 2022 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Feb 15, 2022 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Dec 4, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 19, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 19, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 19, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 19, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 23, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 15, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 25, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 25, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 23, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 23, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 8, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 8, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2015 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 18, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 18, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 18, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 2, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 21, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 17, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 16, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 16, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 30, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 14, 2015 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 16, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2015 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 9, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2015 | ALIE | ASSIGNED TO LIE | — |
| Apr 6, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 6, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 24, 2014 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 8, 2014 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 8, 2014 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 8, 2014 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 7, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 4, 2014 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2014 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 30, 2014 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 25, 2014 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |